Total Funding
85
57
Total FundingSeed raised
Growth Score 85 in past quarter
-5 pts
Heat Score 57 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
45933
Theremia reduces side effects and increases medication efficacy for various patient groups.
- Iris Maréchal: Co-founder & CEO
- Chloé Geoffroy: Co-founder & CTO
About the Company
Theremia is an innovative health tech firm that uses cutting-edge AI technologies to revolutionize drug development. They specialize in neurological illnesses and optimize drug compounds for particular demographic groupings. Their technology offers more effective and individualized healthcare solutions, which increases treatment efficacy and
decreases negative effects.